Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

Table 1

Patients with endometrial cancer divided into subgroups.

Subgroups	Distribution	Numbers
The histopathological type	Type I cancer (endometrial endometrioid adenocarcinoma)
	Type II cancer patients (serous endometrial carcinoma, squamous adenocarcinoma, and clear cell carcinoma)
Histopathological grade of the tumor	G1
	G2
	G3
Clinical stage of the tumor	FIGO I and II
	FIGO III and IV
Myometrial infiltration depth	Superficial myometrial infiltration (<1/2 of the thickness)
	Deep myometrial infiltration (>1/2 of the thickness)
Vascular space involvement	With vascular invasion
	Without vascular invasion
Lymph vessel involvement	With lymph vessel invasion
	Without lymph vessel invasion
Lymph node metastases	With lymph node metastases
	Without lymph node metastases